IPSEN Consumer HealthCare — China drug registrations and re-registration deadlines
5 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-02-28.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20171247 | forlax 聚乙二醇4000散 | 2027-08-30 | 2027-02-28 |
| 国药准字HJ20220094 | Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution 硫酸镁钠钾口服用浓溶液 | 2027-11-29 | 2027-05-29 |
| 国药准字HJ20140560 | Fortrans 复方聚乙二醇电解质散(III) | 2028-12-19 | 2028-06-19 |
| 国药准字HJ20130307 | TANAKAN 银杏叶片 | 2029-02-27 | 2028-08-27 |
| 国药准字HJ20160031 | TANAKAN 银杏叶片 | 2029-02-27 | 2028-08-27 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.